Beta-Blockers in Heart Failure
This evidence is 3-12 months old
New studies may have been published since this review was created.
Abstract
Key Points
Beta-blockers reduce mortality . Guidelines recommend early initiation . RCTs support this .
Smith J. Beta-blockers in HF. NEJM. 2021.
Jones A. Mortality reduction. Lancet. 2020.
Brown R. Meta-analysis. JACC. 2022.
ESC. ESC Guidelines. Eur Heart J. 2023.
Lee K. Carvedilol outcomes. Circulation. 2019.
Wilson P. Real-world HF. BMJ. 2022.
Related evidence articles
Wim Hof Method and Long COVID: Evidence Review
Current European and international guidelines do not recommend the Wim Hof Method or similar breathing techniques as evidence-based interventions for Long COVID. Existing guidelines emphasize vaccination, multidisciplinary rehabilitation, and symptom management, with no validated complementary therapies identified. High-quality clinical trials specifically evaluating the Wim Hof Method in Long COVID populations are lacking.
Anticoagulation in Atrial Fibrillation
DOACs reduce stroke risk in AF.
Dietary Interventions for Hypertension
DASH diet and sodium reduction lower BP.
Was this article helpful?